The Venture Codex Logo

The Venture Codex

Overview

Global venture capital investor in diagnostics and biotechnology startups.

Founded

2023

Deals · 12mo

1

Stage focus

Seed
Series A
Series B

Geographic focus

Belgium
Singapore
South Korea
Spain
...

Sector focus

Health Care

Investment portfolio

10rounds
NAMEDATESIZE
Respiree
Jul 2026Led
$12 MSeries A
DeepUll
Apr 2025Participated
$59 MSeries C
Oxford Cancer Analytics
Jan 2025Led
$11 MSeries A
Proton
Dec 2024Participated
$7 MSeed
GraphAI
Oct 2024Participated
$2 MSeries A
Cognivia
Apr 2024Participated
$17 MOther Equity
Capitainer
Feb 2024Led
$3 MOther Equity
Zetta Genomics
Feb 2024Participated
$2 MSeed
Sendy
Oct 2023Led
$5 MSeries B
Liner
Sep 2022Participated
$8 MSeries B
Respiree
Jul 2026Led
$12 MSeries A
DeepUll
Apr 2025Participated
$59 MSeries C
Oxford Cancer Analytics
Jan 2025Led
$11 MSeries A
Proton
Dec 2024Participated
$7 MSeed
GraphAI
Oct 2024Participated
$2 MSeries A
Cognivia
Apr 2024Participated
$17 MOther Equity
Capitainer
Feb 2024Led
$3 MOther Equity
Zetta Genomics
Feb 2024Participated
$2 MSeed
Sendy
Oct 2023Led
$5 MSeries B
Liner
Sep 2022Participated
$8 MSeries B
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

We Venture Capital: 10 funding rounds are recorded in the selected participation categories.All available history.
We Venture Capital: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A21
Series B11
Series C+01
Other Equity11

Monthly Deal Activity

We Venture Capital: 10 deals are recorded across 50 months.All available history.
We Venture Capital: 10 deals are recorded across 50 months. All available history
MonthDeals
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '231
Nov '230
Dec '230
Jan '240
Feb '242
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '241
Jan '251
Feb '250
Mar '250
Apr '251
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

We Venture Capital: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

We Venture Capital: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7
Enterprise Software3
AI & Machine Learning3
Data, Analytics & IT2
Education & Workforce1
Hardware & Robotics1
Professional Services1
Transportation & Logistics1

Deal Size Distribution

We Venture Capital: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

We Venture Capital: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M3
$5M-$10M3
$10M-$25M3
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

We Venture Capital: Europe has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 5 of 5 regions; European countries are grouped as Europe.

We Venture Capital: Europe has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
Europe5
South Korea2
Singapore1
941051
United States1
We Venture Capital: 20 co-investors are shown, with 15th Rock sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

We Venture Capital: Led accounts for 40% and participating for 60% of round participation.All available history.
We Venture Capital: Led accounts for 40% and participating for 60% of round participation. All available history
CategoryDeals (count)Share (%)
Led440%
Participating660%
We Venture Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
We Venture Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead250%
Co-led250%

Team

No team members found for this fund.